Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Scientists at the Francis Crick Institute and Vividion Therapeutics have developed a new compound that blocks cancer’s growth signal without damaging healthy cells. The discovery, published in Science, marks a major advance in safer, targeted cancer treatments now entering human clinical trials.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox